Mark Cuban Cost Plus Drug Company
-
Why Blue Shield of California Is Shaking Up its Prescription Drug Model
Blue Shield of California is cutting many of its ties with CVS Caremark (though not all) and adding four additional partners for its prescription drug benefits. These partners include Mark Cuban Cost Plus Drug Company and Amazon Pharmacy. The changes are needed to disrupt the current broken system, said Salina Wong, senior director of clinical pharmacy programs at Blue Shield of California.
-
Consumer / Employer, Health Tech
Scripta Insights Partners with Mark Cuban Cost Plus Drug Company
Through Scripta Insights’ app, members of its customers can input the medications they’re taking, and the company will provide a savings report that will show different options on how they can save on their prescriptions. Starting in 2024, Cost Plus Drugs may show up as an option in the savings report.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
How One Company Is Tackling Medication Adherence
Mail order pharmacies like Mark Cuban Cost Plus Drug Company and Amazon’s RxPass are gaining popularity. But they’re missing in-depth consultations with pharmacists. Aspen RxHealth is trying to fill this gap and sees itself as a potential partner for mail order pharmacies.
-
Zócalo Health Teams Up with Mark Cuban’s Pharmacy to Increase Medication Access for Latino Patients
Zócalo Health, a virtual primary care provider designed for Latino patients, recently forged a collaboration with Mark Cuban’s Cost Plus Drugs. Now all Zócalo patients have access to Cost Plus Drugs’ prescriptions, and the provider’s community health workers have been trained to help walk patients through the process of obtaining medications through the pharmacy.
-
Mark Cuban’s Cost Plus Drugs Turns Focus to Employers
Through the partnership, the organizations are launching EmsanaRx Plus. The product supplements employers’ current pharmacy benefit offerings and provides access to Cost Plus Drugs’ discounted medications.
-
Competitor: We Are an Established Option Vis-a-Vis Cuban’s Pharmacy Startup
A customer of Cost Plus Drugs received an email from the company in October stating that “due to skyrocketing demand,” shipping times have been delayed. Marley Drug, a competitor, said its company has not experienced delays and presented itself as an alternative for Americans.
-
Capital Blue Cross to bring low-cost pharmacy option to members and non-members in 2023
It is Mark Cuban Cost Plus Drug Company’s first collaboration with a health plan. The pharmacy company will not be replacing Capital Blue Cross’ existing pharmacy benefits manger, but instead will be an additional option for members to choose.
-
Improving the patient financial experience requires an end to ‘mafia’-style price negotiations
The patient financial experience in the U.S. is poor — patients have a hard time understanding pricing data and they often face exorbitant prices for care and medications. This problem will only get better if the healthcare industry rids itself of price-gouging middlemen and closed-door price negotiations held by businesspeople, according to a recent healthcare innovation panel.
-
In the current venture climate, tech for pharma is recession-proof
Specialty drugs reportedly reached 50 percent of all drug spending in 2020, a figure that has increased significantly over the last decade.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
